Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes. 1986

R C Roozemond, and P van der Geer, and B Bonavida

There is a large body of evidence that supports the notion that NK cells exert important immune surveillance functions in vivo, against a variety of virus-infected and neoplastic cells. However, certain targets are not susceptible to lysis by NK cells. The exact mechanism by which resistance or sensitivity is conferred on target cells is not known. We investigated whether the selectivity to NK lysis is a property of the membrane of the target cell. This was examined by the application of a recently developed method which is aimed at changing the membrane structure of the target cell by cell-liposome fusion. Our studies demonstrate that NK-resistant tumor cells acquired sensitivity to lysis by NK cells after fusion with reconstituted vesicles which contained membrane components derived from NK-sensitive target cells. The fusion required the presence of Sendai virus envelope glycoproteins and exogenous lipids (soybean lecithin and cholesterol) for maximal efficiency. This finding was demonstrated in both the human system (with U937 and Raji as NK-sensitive and -resistant cell lines, respectively) and the rat/murine system (with YAC-1 as NK-sensitive target and P815 and YAC-asc as NK-resistant targets). Both the 51Cr-release assay and the single cell assay showed lysis of the modified target cells in a 3-hr incubation period. The magnitude of the cytotoxic activity was found to depend on the concentration of reconstituted vesicles used in the fusion step. The effect seen was specific because target cells were not lysed when fused with vesicles which contained membrane constituents derived from either NK-resistant targets or NK-sensitive targets from another species (human vs mouse). The resistance of modified target cells to lysis by xenogeneic NK cells was not due to failure of membrane fusion, as detected by immunofluorescence, or to failure to form conjugates. These results demonstrate the feasibility of converting a resistant NK target to a sensitive target by cell-liposome fusion. Furthermore, the data indicate that susceptibility to lysis by NK cells is a property of the membrane composition of the target cell. The significance of these findings is discussed.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007152 Immunologic Capping An energy dependent process following the crosslinking of B CELL ANTIGEN RECEPTORS by multivalent ligands (bivalent anti-antibodies, LECTINS or ANTIGENS), on the B-cell surface. The crosslinked ligand-antigen receptor complexes collect in patches which flow to and aggregate at one pole of the cell to form a large mass - the cap. The caps may then be endocytosed or shed into the environment. Capping, Immunologic,Immunological Capping,Capping, Immunological
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008561 Membrane Fusion The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. Fusion, Membrane,Fusions, Membrane,Membrane Fusions
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R C Roozemond, and P van der Geer, and B Bonavida
January 2016, Biological & pharmaceutical bulletin,
R C Roozemond, and P van der Geer, and B Bonavida
July 2010, Journal of clinical immunology,
R C Roozemond, and P van der Geer, and B Bonavida
August 2014, European journal of immunology,
R C Roozemond, and P van der Geer, and B Bonavida
August 1984, Biochemistry,
R C Roozemond, and P van der Geer, and B Bonavida
March 2004, International immunology,
R C Roozemond, and P van der Geer, and B Bonavida
May 2005, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
R C Roozemond, and P van der Geer, and B Bonavida
January 1999, Biochimica et biophysica acta,
R C Roozemond, and P van der Geer, and B Bonavida
April 2023, Advanced materials (Deerfield Beach, Fla.),
Copied contents to your clipboard!